£1.5m investment aims to give the
bioProcessUK are pleased to inform our members of the TSB’s decision to invest in the future of Regenerative Medicine in the UK
UK regenerative medicine companies are being offered the opportunity to compete for an investment package designed to enable them to boost their productivity. The government-backed Technology Strategy Board has launched a £1.5m collaborative R&D competition call, setting businesses the challenge of developing a better understanding of the best ways to make a profit from regenerative medicine.
The £1.5m is part of a wider £18m Regenerative Medicine investment package from the Technology Strategy Board and is being launched alongside a separate £3m feasibility call.
Click here to read the TSB press release.
For more information or support in applying please contact Mark Bustard, Head of bioProcessUK.
www.bioprocessuk.org
